Dr Reddys
Stocks to watch: Nureca, Max Fin, Axis Bank, DRL, Dredging Corp, Affle
Dr Reddy's launches stomach, esophagus problems treatment drug in US
Dr Reddy's Laboratories launches cancer treatment drug Capecitabine in US
Dr Reddys falls 10% in 2 days, hits over 4-month low post Q3 results
Dr Reddy's posts Q3 profit of Rs 20 crore, revenues at Rs 4,930 crore

Dr Reddy's to acquire select brands from Glenmark in Russia, Ukraine
Weekly stock picks by Religare Broking: Buy Aurobindo Pharma, Marico
A brief history of Indian companies' tryst with class action suits
BSE Healthcare index hits record high; Laurus Labs, Dr Reddy's at new highs
Sensex ends 134 pts lower, Nifty settles at 11,505; Nifty Pharma jumps 5%

Russia ropes in Dr Reddy's to sell 100 mn Covid-19 vaccine doses; stk up 4%
New launches, patents: Multiple catalysts for Dr Reddy's US business
Cipla tweaks management structure to mobilise second level of executives
TCS, Infosys, and Dr Reddy's shares hit fresh record highs
India's coronavirus drug market set for price war as firms ready launches
Covid-19 crisis: Made-in-India remdesivir may come by end of June
Revised Wockhardt deal boosts prospects of Dr Reddy's India business
Dr Reddy's Q4 PBT up 22% at Rs 714 cr on buoyant US, European business
Dr Reddy's gets USFDA inspection closure report fo Srikakulam unit
Dr Reddy's Labs hits over 4-year high, surges 62% from March low